or
forgot password

Improving Followup of Positive Fecal Occult Blood Tests


N/A
18 Years
80 Years
Not Enrolling
Both
Colorectal Cancer

Thank you

Trial Information

Improving Followup of Positive Fecal Occult Blood Tests


Screening programs using the fecal occult blood test (FOBT) have demonstrated a significant
reduction in colorectal cancer mortality, although only when accompanied by a complete
diagnostic evaluation of the colon in the setting of a positive result. 90% of patients
with a positive FOBT result have completed a subsequent colonoscopy within Harvard Vanguard
Medical Associates. This project will use a pre-post study design to increase the rate of
followup colonoscopy in the setting of positive FOBT results. Patients in the intervention
group will receive a personalized mailing highlighting their positive result and need for
colonoscopy, followed by telephone outreach from a centralized gastroenterology scheduling
office. The primary outcome will be the performance of colonoscopy, however we will also
perform chart reviews to identify predictors of completing appropriate followup.


Inclusion Criteria:



- Patients with positive fecal occult blood test during 2004, 2005, and 2006; and no
colonoscopy following this test result

Exclusion Criteria:

- Patients with active cardiopulmonary disease or limited life expectancy due to severe
illness such as malignancy

- Colonoscopy within 5 years prior to positive fecal occult blood test

- Age > 80 years

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research

Outcome Measure:

Performance of colonoscopy

Outcome Time Frame:

6 months

Principal Investigator

Thomas D Sequist, MD, MPH

Investigator Role:

Principal Investigator

Investigator Affiliation:

Harvard Vanguard Medical Associates

Authority:

United States: Institutional Review Board

Study ID:

Sequist Colorectal Cancer

NCT ID:

NCT00436137

Start Date:

June 2007

Completion Date:

March 2008

Related Keywords:

  • Colorectal Cancer
  • Colorectal cancer
  • Fecal occult blood test
  • Abnormal test result
  • Missed diagnosis
  • Delayed diagnosis
  • Colorectal Neoplasms

Name

Location

Harvard Vanguard Medical Associates Newton, Massachusetts  02466